Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|December 22, 2025
[Analysis of mpox cases co-infected with HIV in Zhejiang Province]Y P Yao, W Cheng, J Jiang, et al.
Anticancer Research|January 15, 1998
A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancersK H Yeh, A L Cheng, M T Lin, et al.
Rheumatology (Oxford, England)|May 25, 2023
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohortAbeer Ghuman, Dinesh Khanna, Celia J F Lin, et al.
British Journal of Cancer|March 17, 2005
Phase II study of weekly vinorelbine and 24-h infusion of high-dose 5-fluorouracil plus leucovorin as first-line treatment of advanced breast cancerK H Yeh, Y S Lu, C H Hsu, et al.
BMC Musculoskeletal Disorders|April 29, 2017
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyJonathan D Adachi, Henry G Bone, Nadia S Daizadeh, et al.
Physical Review Letters|September 6, 2014
Role of valence fluctuations in the superconductivity of Ce122 compoundsH Yamaoka, Y Ikeda, I Jarrige, et al.
Breast Cancer Research and Treatment|October 17, 1998
High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancersK H Yeh, M T Lin, D T Lin, et al.
The Journal of Rheumatology|November 17, 2017
Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical SettingArthur N Lau, Matthew Wong-Pack, Rod Rodjanapiches, et al.
Kidney International|March 29, 2024
A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathyRichard Lafayette, Sean Barbour, Rubeen Israni, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|August 18, 2022
[Analysis on infection risk in secondary close contacts of COVID-19 patients]B Yi, Y R Chu, Y Chen, et al.
Pageof 7